A major clinical study by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has found that an immune-based cancer drug may help reduce the spread of Merkel cell carcinoma, a rare but aggressive type of skin cancer, when used soon after surgery….
A major clinical study by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has found that an immune-based cancer drug may help reduce the spread of Merkel cell carcinoma, a rare but aggressive type of skin cancer, when used soon after surgery….